Evoke Pharma Inc Contracts & Agreements

Seventh Amendment to Standard Office Lease, dated October 16, 2024, by and between the Company and SB Corporate Centre III-IV, LLC (Filed With SEC on November 7, 2024)

Second Amended and Restated Employment Agreement, effective as of August 8, 2024, by and between the Company and Matthew D'Onofrio (Filed With SEC on November 7, 2024)

Amended and Restated Employment Agreement, effective as of August 8, 2024, by and between the Company and Mark Kowieski (Filed With SEC on November 7, 2024)

Amended and Restated Employment Agreement, effective as of August 8, 2024, by and between the Company and Marilyn Carlson, M.D (Filed With SEC on November 7, 2024)

Letter Agreement, dated September 27, 2024, by and between the Company and certain affiliates of Nantahala Capital Management, LLC (Filed With SEC on September 27, 2024)

Form of Exercise Price Warrant Amendment (Filed With SEC on September 27, 2024)

EVOKE PHARMA, INC. AMENDMENT TO SERIES C COMMON STOCK PURCHASE WARRANT (Filed With SEC on September 27, 2024)

Form of Warrant Amendment (Filed With SEC on June 20, 2024)

Form of Warrant Amendment (Filed With SEC on March 25, 2024)

Manufacturing Services Agreement dated November 7, 2017, between the Company and Patheon UK Limited (Filed With SEC on March 14, 2024)

Form of Representative Warrant (Filed With SEC on February 14, 2024)

Underwriting Agreement, dated February 8, 2024, by and among Evoke Pharma, Inc., Craig-Hallum Capital Group LLC and Laidlaw & Company (UK) Ltd (Filed With SEC on February 9, 2024)

Underwriting Agreement (Filed With SEC on January 11, 2024)

Form of Series C Warrant (Filed With SEC on January 11, 2024)

Form of Series B Warrant (Filed With SEC on January 11, 2024)

Form of Series A Warrant (Filed With SEC on January 11, 2024)

Form of Common Warrant (Filed With SEC on December 15, 2023)

Form of Pre-Funded Warrant (Filed With SEC on December 15, 2023)

Underwriting Agreement (Filed With SEC on December 15, 2023)

Sixth Amendment to Standard Office Lease dated October 9, 2023, between the Company and SB Corporate Center III-IV, LLC (Filed With SEC on November 9, 2023)

Non-Employee Director Compensation Policy, as Amended and Restated Effective February 8, 2023 (Filed With SEC on August 10, 2023)

Non-Employee Director Compensation Policy, as Amended and Restated Effective February 8, 2023 (Filed With SEC on May 15, 2023)

Evoke Pharma, Inc. Amended and Restated 2013 Equity Incentive Award Plan (Filed With SEC on May 11, 2023)

Evoke Pharma, Inc. Amended and Restated 2013 Employee Stock Purchase Plan (Filed With SEC on May 11, 2023)

Amendment No. 2 to the Commercial Services Agreement, dated as of November 3, 2022, between the Company and Eversana Life Sciences Services, LLC (Filed With SEC on November 9, 2022)

Amendment No. 1 to the Commercial Services Agreement, dated as of February 1, 2022, between the Company and Eversana Life Sciences Services, LLC (Filed With SEC on May 10, 2022)

Fourth Amendment to Standard Office Lease dated February 3, 2022 between the Company and SB Corporate Centre III-IV, LLC (Filed With SEC on March 8, 2022)

Non-Employee Director Compensation Policy, as Amended and Restated Effective February 2, 2022 (Filed With SEC on March 8, 2022)

Non-Employee Director Compensation Policy, as Amended and Restated Effective January 27, 2021 (Filed With SEC on March 11, 2021)

Third Amendment to Standard Office Lease dated December 15, 2020 between the Company and SB Corporate Centre III-IV, LLC (Filed With SEC on March 11, 2021)

Underwriting Agreement, dated January 13, 2021, by and between Evoke Pharma, Inc. and Laidlaw &Company (UK) Ltd (Filed With SEC on January 14, 2021)

3PL Agreement between the Company and Eversana Life Science Services, Inc. dated August 27, 2020 (Filed With SEC on November 10, 2020)

Commercial Services Agreement, dated as of January 21, 2020, between the Company and Eversana Life Sciences Services, LLC (Filed With SEC on May 12, 2020)

Non-Employee Director Compensation Policy, as Amended and Restated, Effective February 28, 2020 (Filed With SEC on May 12, 2020)

Loan Agreement, dated as of January 21, 2020, between the Company and Eversana Life Sciences Services, LLC (Filed With SEC on May 12, 2020)

Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 12, 2020)

Second Amendment to Standard Office Lease dated December 6, 2019 between the Company and SB CorporateCentre III IV, LLC (Filed With SEC on March 12, 2020)

Commercial Services Agreement, dated as of January 5, 2019, between the Company and Novos Growth, LLC.(certain portions of this exhibit have been omitted and are subject to... (Filed With SEC on May 8, 2019)

First Amendment to the Commercial Services Agreement, dated as of February 28, 2019, between the Company and Novos Growth, LLC (Filed With SEC on May 8, 2019)

Non-Employee Director Compensation Policy, as Amended and Restated Effective February 6, 2019 (Filed With SEC on March 6, 2019)

First Amendment to Standard Office Lease dated September 27, 2018 between the Company and SB Corporate Centre III-IV, LLC (Filed With SEC on March 6, 2019)

Amendment to Asset Purchase Agreement entered into by and between Evoke Pharma, Inc. and Mallinckrodt ARD Inc. dated March 21, 2018 (Filed With SEC on May 14, 2018)

Form of Warrant Amendment, dated March 29, 2018 (Filed With SEC on April 4, 2018)

Form of Warrant Amendment, dated March 22, 2018 (Filed With SEC on March 23, 2018)

Manufacturing Services Agreement dated November 7, 2017, between the Company and Patheon UK Limited (Filed With SEC on March 7, 2018)

EVOKE PHARMA, INC. MASTER SERVICES AGREEMENT (Filed With SEC on August 14, 2017)

Non-Employee Director Compensation Policy, as Amended and Restated Effective January 25, 2017 (Filed With SEC on May 15, 2017)

OFFICE LEASE AGREEMENT BETWEEN SB CORPORATE CENTRE III-IV, LLC AS LANDLORD AND EVOKE PHARMA, INC. TABLE OF CONTENTS (Filed With SEC on March 15, 2017)

AMENDMENT TO AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on March 15, 2017)

AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on March 15, 2017)

2,413,793 Shares EVOKEPHARMA, INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on February 16, 2017)

FORM OF AMENDMENT TO COMMON STOCK PURCHASE WARRANT (Filed With SEC on December 16, 2016)

CERTAIN MATERIAL (INDICATED BY AN ASTERISK) HAS BEEN OMITTED FROM THIS DOCUMENT PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY... (Filed With SEC on August 15, 2016)

COMMON STOCK PURCHASE WARRANT EVOKE PHARMA, INC. (Filed With SEC on August 1, 2016)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on August 1, 2016)

COMMON STOCK PURCHASE WARRANT EVOKE PHARMA, INC. (Filed With SEC on July 20, 2016)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on July 20, 2016)

EVOKE PHARMA, INC. CommonStock (par value $0.0001 per share) At Market Issuance Sales Agreement (Filed With SEC on April 15, 2016)

MODIFICATION AGREEMENT (Filed With SEC on March 10, 2016)

EVOKE PHARMA, INC. Non-Employee DIRECTOR COMPENSATION POLICY (As Amended and Restated Effective January 28, 2016) (Filed With SEC on March 10, 2016)

THIRD AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on March 1, 2016)

SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on October 7, 2015)

FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on May 14, 2015)

WARRANT TO PURCHASE STOCK (Filed With SEC on May 28, 2014)

EVOKE PHARMA, INC. LOAN AND SECURITY AGREEMENT (Filed With SEC on May 28, 2014)

THIRD AMENDMENT TO MASTER SERVICES AGREEMENT (Filed With SEC on March 25, 2014)

STANDARD OFFICE LEASE (Filed With SEC on March 25, 2014)

SECOND AMENDMENT TO MASTERSERVICES AGREEMENT (Filed With SEC on March 25, 2014)

EMPLOYMENT AGREEMENT (Filed With SEC on December 2, 2013)

UNDERWRITING AGREEMENT between EVOKE PHARMA, INC. and AEGIS CAPITAL CORP., as Representative of the Several Underwriters EVOKE PHARMA, INC. UNDERWRITING AGREEMENT (Filed With SEC on August 30, 2013)

EVOKE PHARMA, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (Filed With SEC on August 30, 2013)

EVOKE PHARMA, INC. 2013 EQUITY INCENTIVE AWARD PLAN ARTICLE 1. PURPOSE (Filed With SEC on August 30, 2013)

Additional abbreviations may also be used though not in the above list. (Filed With SEC on August 16, 2013)

Form of Representatives Warrant Agreement (Filed With SEC on August 16, 2013)

UNDERWRITING AGREEMENT between EVOKE PHARMA, INC. and AEGIS CAPITAL CORP., as Representative of the Several Underwriters EVOKE PHARMA, INC. UNDERWRITING AGREEMENT (Filed With SEC on August 16, 2013)

ASSET PURCHASE AGREEMENT Dated as of June 1, 2007 by and among Evoke Pharma, Inc., a Delaware corporation, PURCHASER and QuestcorPharmaceuticals, Inc., a California corporation,... (Filed With SEC on July 3, 2013)

EVOKE PHARMA, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (Filed With SEC on June 14, 2013)

EVOKE PHARMA, INC. 2013 EMPLOYEE STOCK PURCHASE PLAN ARTICLE 1. PURPOSE (Filed With SEC on June 14, 2013)

EVOKE PHARMA, INC. 2013 EQUITY INCENTIVE AWARD PLAN ARTICLE 1. PURPOSE (Filed With SEC on June 14, 2013)

AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on June 14, 2013)

LOAN AND SECURITY AGREEMENT (Filed With SEC on May 24, 2013)

ASSET PURCHASE AGREEMENT Dated as of June 1, 2007 by and among Evoke Pharma, Inc., a Delaware corporation, PURCHASER and QuestcorPharmaceuticals, Inc., a California corporation,... (Filed With SEC on May 24, 2013)

EVOKE PHARMA, INC. 2013 EMPLOYEE STOCK PURCHASE PLAN ARTICLE 1. PURPOSE (Filed With SEC on May 24, 2013)

EVOKE PHARMA, INC. 2013 EQUITY INCENTIVE AWARD PLAN ARTICLE 1. PURPOSE (Filed With SEC on May 24, 2013)

EVOKE PHARMA, INC. 2007 EQUITY INCENTIVE PLAN ARTICLE 1 PURPOSE (Filed With SEC on May 24, 2013)

INDEMNIFICATION AGREEMENT (Filed With SEC on May 24, 2013)

WARRANT TO PURCHASE STOCK (Filed With SEC on May 24, 2013)

EVOKE PHARMA, INC. INVESTOR RIGHTS AGREEMENT June 1, 2007 TABLE OF CONTENTS (Filed With SEC on May 24, 2013)

Category

Industry

Companies

Contracts

Evoke Pharma Inc Contracts & Agreements